CORDIS · 234810 · FP7
COMPLOIDS Physics of Complex Colloids: Equilibrium and Driven
Coordinator: UNIVERSITAT WIEN (AT)
With progress in nanotechnology, biophysics, and polymer synthesis, colloidal science has reached a new level of importance. A large variety of complex colloids of different shapes, with binding specificity, and variable softness has been synthesized, opening quite exciting ways for engineering materials at the nanoscale. The purpose of COMPLOIDS is to obtain a fundamental understanding of the Physics governing the self-organization and the dynamical behavior of complex colloidal particles in the bulk, under confinement and out of equilibrium. For this purpose, the partners will consider a va…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €4.7M awarded to the consortium. The project runs over approximately 4 years from 2009-11-01 to 2013-10-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from AT
see all →- EMPOWER — Eco-operated, Modular, highly efficient, and flexible multi-POWERtrain for long-haul heavy-duty vehicles101096028 · HORIZON · €18.0M
- M-ERA.NET3 — ERA-NET for research and innovation on materials and battery technologies, supporting the European Green Deal.958174 · H2020 · €15.0M
- iPC — individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology826121 · H2020 · €14.7M
- MORE-TEM — MOmentum and position REsolved mapping Transmission Electron energy loss Microscope951215 · H2020 · €14.0M
- PoCCardio — Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio)101095432 · HORIZON · €14.0M
- ThoriumNuclearClock — Thorium nuclear clocks for fundamental tests of physics856415 · H2020 · €13.8M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the MC-ITN funding scheme.
- What is the EU contribution?
- The European Commission contributes €4.7M toward a total project budget of €4.7M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by UNIVERSITAT WIEN (AT).
- What is the project timeline?
- The project runs from 2009-11-01 to 2013-10-31 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 234810.